Summit Therapeutics (SMMT) Q4 2024 Earnings

30OctConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.07
-0.06
-0.06
-0.05

Details

Expected EPS
-0.066755
Actual EPS
-0.05
Surprise EPS
0.02
Surprise Percent
+25.1%

Description

Summit Therapeutics (SMMT) has reported earnings of -0.05 per share for Q4 2024.

0 Comments

Share your thoughts